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doi:10.1016/j.pedneo.2011.05.008Background: There is no national data on group B streptococcus (GBS) infection in Taiwan. We
investigated incidence of maternal GBS colonization and neonatal GBS infection rate and clin-
ical pictures of neonatal GBS infection to estimate the value of intrapartum chemoprophy-
lactic strategy in Taiwan.
Methods: From January 2004 to June 2005, a prospective study to estimate maternal coloniza-
tion rate by maternal rectovaginal culture at six hospitals was conducted. Neonatal GBS infec-
tion rate based on inborn infants was calculated retrospectively from January 2001 to June
2005; clinical pictures of infants diagnosed with invasive GBS disease were reviewed.
Results: Maternal colonization rate of GBS was around 20% at hospital base, incidence of
neonatal GBS infection was 1 per 1000 live births of infants born at hospitals. There were
221 infants with GBS infection: in 142, the disease occurred within 7 days of birth (early-
onset disease, EOD), and in 79, it developed later (late-onset disease). Infantile EOD was
more often seen in mothers with premature rupture of membrane, often accompanied by
respiratory failure necessitating ventilator support. Infants with late-onset disease oftenof Pediatrics, Cheng Ching General Hospital, No. 139, Ping-Tien Street, Taichung, Taiwan.
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Group B streptococcal infection in Taiwan 191manifested fever, leukopenia, thrombocytopenia, and meningitis. Fifteen infants died,
mostly of EOD type (12 of 15). Risk factors of mortality included rescue at delivery room,
leukopenia, thrombocytopenia, sepsis, respiratory distress, persistent hypertension of
newborn, respiratory failure needing intensive respiratory support (intermittent mandatory
ventilator and high frequency oscillatory ventilator), surfactant use, shock, and congenital
heart diseases.
Conclusions: We concluded that universal maternal rectovaginal culture of GBS with intrapar-
tum antibiotic prophylaxis is an urgent call to reduce EOD and mortality because of GBS
infection in neonates in Taiwan.
Copyright ª 2011, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Group B streptococcus (GBS), or Streptococcus agalactiae,
is the most common cause of early neonatal infection, with
5e20% mortality and serious complications.1,2 Since
implementation of intrapartum antibiotic prophylaxis in
1996, incidence of early-onset disease (EOD) of GBS has
dropped by 50e85% in the United States.3 Incidence of
invasive GBS infection, which was defined as isolation of
GBS from a normally sterile site [such as blood or cere-
brospinal fluid (CSF) or, less commonly, joint, pleural, or
pericardial fluid],4 is around 0.2e5.4 infants per 1000 live
births before intrapartum antibiotic prophylaxis.5,6
GBS is commonly found in the female genital tract and
exists at a lower rate in male urethras.7 An estimated of
15e28.7% women at childbearing age are colonized with
GBS.8,9 Approximately 50% of infants born from these
women will become infected,10 with 1e2% of infants with
GBS colonization developing disease.11 There were several
reports of neonatal GBS infection in Taiwan,12e16 but data
were from regional single institutes that could not validly
represent incidence of neonatal GBS infection in Taiwan.
Although researchers believe that Taiwan needs its own
policy to reduce neonatal GBS infection, no intrapartum
antibiotics strategy exists in Taiwan at present because of
lack of accurate data. We speculated that maternal colo-
nization and incidence of neonatal GBS infection and
mortality rate of EOD of GBS by hospital base will match
those in previous reports; intrapartum chemoprophylactic
strategy might be warranted for Taiwan to reduce GBS
infection in neonates.2. Materials and Methods
2.1. Maternal colonization
From July 2004 to June 2005, we performed a prospective
study of maternal rectovaginal colonization rate from six
hospitals (China Medical University Hospital, Taichung
Veterans General Hospital, Shinyaton Hospital, Cheng Ching
Hospital, Mackay Memorial Hospital, and Chang Gung
Memorial Hospital). This study encouraged pregnant women
to do rectovaginal culture, paid by themselves. Collection
of cultures was conducted by swabbing both lower vagina
and rectum (through the anal sphincter) between 35 and 37
weeks’ gestation.172.2. Incidence of neonatal GBS infection
From January 2002 to June 2005, a retrospective study
enrolled all infants born in the hospital in six medical
centers (China Medical University Hospital, Taichung
Veterans General Hospital, Changhua Christian Hospital,
National Taiwan University Hospital, Chang Gung Memorial
Hospital, and Mackay Memorial Hospital) and recorded
inborn infants with GBS infection to calculate the neonatal
GBS infection rate.
2.3. Clinical pictures of neonatal GBS infection
From January 2002 to June 2005, all infants with invasive
GBS infection and with gestational age more than 24 weeks
and less than 3 months of age, including inborn and trans-
ferred infants, were enrolled. Invasive GBS infection
included GBS pneumonia, bacteremia, or meningitis diag-
nosed at six medical centers and five hospitals (Cheng
Ching, Tai-An, Taipei City, Shin Kong Wu Ho-Su Memorial,
and Taiwan Adventist) were reviewed retrospectively.
Infants were identified from computerized medical records
and reports of positive body fluid culture.
GBS was identified based on gram-stained smear and
growth characteristics, production of beta-hemolysin on
sheep blood agar, resistance to bacitracin disc, negative
hydrolysis of bile-esculin agar, and positive CAMP test
showing typical arrowhead enlargement by GBS of the zone
of hemolysis caused by Staphylococcus aureus; this was
confirmed by Streptex agglutination test (Wellcome Diag-
nostics, Dartford, UK). Typing of GBS isolates was not
routinely performed. The following items were reviewed:
gender, gestation age, body weight, age at onset, delivery
method, chorioamnionitis, preterm delivery, premature
rupture of membrane (PROM), Apgar score at 1 and 5
minutes, rescue at delivery room, neonatal fever, white
blood cell count, platelet count, sepsis, meningitis, shock,
respiratory distress, persistent pulmonary hypertension,
and mode of ventilatory support.
For data collection, the following terminologies were
defined: PROM, rupture of membranes was more than
18 hours; chorioamnionitis: maternal fever, uterine
tenderness, foul smelling vaginal discharge/amniotic fluid,
maternal leukocytosis, maternal and/or fetal tachycardia;
very low birth weight, birth weight less than 1500 g. EOD
means symptoms present at less than 7 days of age. Late-
onset disease (LOD) means symptoms present at 7 days of
Table 1 Incidence of maternal GBS colonization
(prospective study)
Hospital All mothers GBS(þ) mothers Colonization rate
1 1028 155 0.15
2 109 12 0.11
3 1247 162 0.13
4 168 31 0.18
5 452 101 0.22
6 1581 457 0.29
Total 4585 918 0.20
GBSZ group B streptococcus; Hospital 1Z China Medical
University Hospital; Hospital 2Z Taichung Veterans General
Hospital; Hospital 3Z Shinyaton Hospital; Hospital 4Z Cheng
Ching Hospital; Hospital 5ZMackay Memorial Hospital;
Hospital 6Z Chang Gung Memorial Hospital.
Table 3 Clinical features and laboratory findings of early
and late group B streptococcus infection
Clinical findings Early onset
(7 d)
[nZ 142 (%)]
Late onset
(>7 d)
[nZ 79 (%)]
p
Pneumonia 53 (37.3) 8 (10.1) 0.000
Sepsis 83 (58.4) 54 (68.3) 0.146
Meningitis 29 (20.4) 30 (37.9) 0.004
UTI 80 (56.3) 38 (48.1) 0.239
Shock 29 (20.4) 11 (13.9) 0.229
PPHN 4 (2.8) 0 (0) 0.132
Surfactant use 18 (12.6) 3 (3.7) 0.031
IMV 29 (20.4) 8 (10.1) 0.049
HFOV 18 (12.6) 4 (5.0) 0.070
Mortality 12 (8.4) 3 (3.8) 0.187
Fever >38C 41 (28.8) 60 (75.9) 0.000
Leukopenia <5000 20 (14.0) 20 (25.3) 0.037
Thrombocytopenia 12 (8) 1 (1) 0.029
HFOVZ high frequency oscillatory ventilator; IMVZ intermit-
tent mandatory ventilator; PPHNZ persistent pulmonary
hypertension in neonate; thrombocytopeniaZ platelet count
less than 100,000/mm3; UTIZ urinary tract infection.
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from blood culture with clinical symptoms. Meningitis: (1)
Positive culture and/or positive latex particle agglutination
test of a nontraumatic CSF; (2) positive gram-stained smear
of CSF and/or significant pleocytosis in a nontraumatic CSF,
in the course of GBS infection; or (3) pathologic findings
consistent with acute meningeal inflammation. Pneumonia:
(1) GBS infection; (2) abnormal chest roentgenogram
(consistent with respiratory distress syndrome, pneumonia,
transient tachypnea in newborn); (3) respiratory signs and
symptoms; or (4) oxygen requirement. Shock: hypotension,
corrected for birth weight, requiring dopamine and/or
albumin administration. Urinary tract infection (UTI): pure
culture of GBS from urine sample obtained by bladder tap
or sterile catheterization. Persistent pulmonary hyperten-
sion in neonate (PPHN) was diagnosed by persistent
hypoxemia despite application of 100% oxygen in conjunc-
tion with mechanical ventilation and right-to-left or bidi-
rectional shunt from the ductus arteriosus and/or foramen
ovale revealed by an echocardiogram. Fatality: any infant
death attributed to complications of GBS infection under
diagnosis of invasive GBS disease.
2.4. Statistical methods
Significance of comparison between proportions was
determined by the c2 test with Yates correction forTable 2 Incidence of neonatal group B streptococcus infection
Infected persons/no. of newborns 2002 2003
Hospital 1 0/2358 2/24
Hospital 2 0/1146 1/11
Hospital 3 0/2913 0/25
Hospital 4 2/2517 2/29
Hospital 5 5/5233 11/50
Hospital 6 5/4403 6/44
Mean
Hospital 1Z China Medical University Hospital; Hospital 2Z Taichu
Hospital; Hospital 4Z National Taiwan University Hospital; Hosp
Memorial Hospital.continuity when required. A p value less than 0.05 was
considered statistically significant.
3. Results
Prospective maternal rectovaginal colonization of GBS was
20% in average (11e29%) (Table 1). Retrospective chart
review plotted incidence of neonatal GBS infection as 1.1
per 1000 live births, based on inborn babies in medical
centers (Table 2). Over 4 years at 11 hospitals, 221 infants
showed GBS infection, 142 presented within 7 days of life,
and 79 developed diseases later. Pneumonia developed in
61, sepsis in 136, meningitis in 59, UTI in 118, shock in 40,
and PPHN in 4 (Table 3). Thirty-seven had severe respira-
tory failure requiring intermittent mandatory ventilator
(IMV) support, and 10 required high frequency oscillatory
ventilator (HFOV) (Table 3). Twenty-two received surfac-
tant therapy. Fifteen died, mostly of the early type (12 of
15, 80.0%). Overall mortality was 15 of 221 (6.8%); mortality(retrospective study in inborn)
2004 2005 Total
01 3/2063 4/2321 9/9143 (0.0010)
26 1/1037 1/1155 3/5856 (0.0005)
48 1/2006 4/1987 5/9454 (0.0005)
36 5/2254 4/2108 13/9815 (0.0013)
01 6/4303 5/3763 27/16136 (0.0017)
99 6/3629 0/3605 17/12963 (0.0013)
74/63367 (0.0011)
ng Veterans General Hospital; Hospital 3Z Changhua Christian
ital 5Z Chang Gung Memorial Hospital; Hospital 6ZMackay
Table 4 Differences of obstetric and neonatal risk factors between early and late onset of group B streptococcus infection
Risk factors EOD (7 d) [nZ 142 (%)] LOD (>7 d) [nZ 79 (%)] p
Maternal fever 3 (2.1) 1 (1.2) 0.162
Chorioamnionitis 10 (7.0) 2 (2.5) 0.156
PROM >18 hr 28 (19.7) 5 (6.3) 0.007
Prenatal antibiotics 6 (4.2) 4 (5.0) 0.773
NSD 108 (76.0) 55 (69.6) 0.297
Rescue at DR 24 (16.9) 6 (7.5) 0.052
Male 78 (54.9) 36 (45.5) 0.182
Gestational age  34 wk 26 (18.3) 11 (13.9) 0.402
Birth weight  2500 g 40 (28.1) 17 (21.5) 0.278
Apgar score 1 min <6 11 (7.7) 5 (6.3) 0.696
Apgar score 5 min <6 3 (2.1) 3 (3.7) 0.460
AntibioticsZmother received antibiotic; DRZ delivery room; EODZ early-onset disease; LODZ late-onset disease; NSDZ normal
spontaneous delivery; PROMZ premature rupture of membrane for more than 18 hours.
Group B streptococcal infection in Taiwan 193of EOD was 12 of 142 (8.5%), with 3 of 79 (3.8%) in LOD
(Table 3).
Pneumonia, respiratory failure with IMV support and
surfactant use, thrombocytopenia (platelet count less than
100,000/mm3) occurred more often in EOD group; and
meningitis, fever more than 38C, leukopenia (white blood
cell count less than 5000/mm3) occurred more in LOD
group (Table 3).
PROM is the most important risk factor for EOD of GBS.
There is no significance among maternal fever, cho-
rioamnionitis, prenatal antibiotics use, normal spontaneous
delivery, rescue at delivery room, gestational age less than
34 weeks, and birth weight less than 2500 g (Table 4). Risk
factors of mortality included rescue at delivery room
(pZ 0.002), leukopenia (pZ 0.022), thrombocytopenia
(pZ 0.000), sepsis (pZ 0.001), respiratory distressTable 5 Risk factors of mortality in GBS infection
Risk factors Survival [nZ 206 (%)]
PROM >18 hrs 30 (14.5)
CS 52 (25.2)
Rescue at delivery room 24 (11.6)
Inborn 95 (46.1)
Male 108 (52.4)
GA 34 wk 34 (16.5)
BBW 2500 g 50 (24.2)
Neonatal fever >38C 100 (48.5)
Leukocyte <5000 34 (16.5)
Platelet <100,000 8 (3.8)
Sepsis 122 (59.2)
Respiratory distress 53 (25.7)
PPHN 1 (0.4)
Meningitis 56 (27.1)
Surfactant 16 (7.7)
IMV 27 (13.1)
HFOV 4 (1.9)
Shock 25 (12.1)
Congenital heart disease 7 (3.3)
BBWZ birth body weight; CSZ cesarean section; GAZ gestational
mittent mandatory ventilator; PPHNZ persistent pulmonary hyperte
more than 18 hours.(pZ 0.020), PPHN (pZ 0.000), surfactant use (pZ 0.001),
IMV (pZ 0.000), HFOV (pZ 0.000), shock (pZ 0.000), and
congenital heart disease (pZ 0.002) (Table 5).4. Discussion
This is the first prospective study of maternal rectovaginal
GBS cultures with a large sample size in Taiwan; results
revealed incidence of maternal GBS colonization of around
20% (918/4585), which is within the range of previous
reports.8e10 Hospitals 5 and 6 showed a higher colonization
rate, which may prove more accurate than other hospitals;
they performed nearly universal maternal GBS screening.
Hospital 2 showed the lowest colonization rate, possibly
owing to small sample size of maternal GBS cultures.Fatality [nZ 15 (%)] p
3 (20.0) 0.568
3 (20.0) 0.650
6 (40.0) 0.002
6 (40.0) 0.646
9 (60.0) 0.570
3 (20.0) 0.726
7 (46.6) 0.055
2 (13.3) 0.008
6 (40.0) 0.022
5 (33.3) 0.000
15 (100) 0.001
8 (53.3) 0.020
3 (20.0) 0.000
3 (20.0) 0.543
5 (33.3) 0.001
10 (66.6) 0.000
6 (40.0) 0.000
15 (100) 0.000
3 (20.0) 0.002
age; HFOVZ high frequency oscillatory ventilator; IMVZ inter-
nsion of newborn; PROMZ premature rupture of membrane for
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and race.1
Many pediatricians and obstetricians believed GBS
infection not prevalent in Taiwan.16,17 The impression of
a low incidence of GBS infection in Taiwan may arise from
few rectovaginal cultures done for expectant women plus
antibiotics prescribed for high-risk pregnant mothers very
often. That resulted in a partial or complete treatment of
GBS colonization in pregnant women, masking low inci-
dence of invasive GBS disease for infants. It is interesting
that if we calculate incidence of newborn infection from
the colonization rate of pregnant women, the answer is
0.1%, (0.20 maternal colonization 0.5 newborn colo-
nization 0.01 newborn infection rate), and the magic
number by calculation matched that of retrospective study
of GBS infection in newborn infants.
Most infections in newborns occur within the first week
of life defined as EOD by Baker et al.18 It usually mani-
fests as sepsis or pneumonia and varies from 1e4 cases
per 1000 live births in the United States to 0.3e1 cases
per 1000 live births in Europe19,20 and is associated with
high mortality rates.21 Bromberger et al22 found that 95%
of neonates with GBS-positive infections and signs of
sepsis exhibit them in the first 24 hours of life. Among
GBS infections, sepsis was most common in both early and
late onset types in our study. In the EOD group, sepsis was
the most common clinical presentation, followed by UTI.
Pneumonia was found in 53 (37.3%) infants and meningitis
was found in 29 (20.4%) infants in the EOD group, similar
to reports of Hoshina et al23 in Japan, and Chung et al18
from Chang Gung Memorial Hospital of Kaohsiung. EOD of
GBS infection is usually from vertical transmission from
mother to child; not surprisingly, PROM was the most
common risk factor of infection, this further making
antibiotic prophylactic strategy against vertical trans-
mission valuable.
Thirty-eight (26.8%) infants in the EOD group developed
respiratory failure necessitating ventilator support
(including HFOV or IMV). Ho et al16 reported 50% with
respiratory distress in EOD group of GBS infection over an
11-year review. Chung et al18 also reported respiratory
distress in 50% of EOD babies. Because PROM was the most
often seen risk factor in the EOD group, it’s reasonable to
speculate that infants in EOD group might aspirate the
infectious amniotic fluid to get pneumonia and suffer from
respiratory distress soon after they are born. McKenna and
lams24 found that LOD usually manifests as neonatal sepsis
or meningitis with lower mortality. Our study showed sepsis
(54, 68.3%) as the most common manifestation in LOD of
GBS infection, followed by UTI (38, 48.1%), meningitis
(37.9%), and pneumonia (10.1%). Fever was found in 60
(75.9%) infants and leukopenia in 20 (25.3%) of LOD (both
significant); infants in LOD group seemed to have more
obvious systemic reaction to GBS infection.
Although Hoshina et al23 reported deaths significantly
higher in LOD than in EOD, Liao et al12 reported death rates
higher in EOD. No significant difference in mortality was
found between EOD and LOD (Table 3). There was no
statistical significance between maternal fever, cho-
rioamnionitis, and premature labor (less than 34 weeks)
between the EOD and LOD group compared with the
previous report,18 maybe because of low patient numbers.There is limited data regarding risk factors of mortality
because of GBS infection in Taiwan. Chung et al18 reported
that gestational age and pneumonia were two most
important factors influencing the mortality rate. Our study
revealed risk factors of mortality: rescue at delivery room,
leukopenia, thrombocytopenia, sepsis, respiratory distress
syndrome, PPHN, surfactant use, respiratory failure with
either IMV or HFOV, shock, and congenital heart disease.
Owing to limited number of fatalities, we performed no
further multivariate logistic regression analysis. Mortality in
this study was 6.8%, within the range (5e20%) of other
reports,1,2 most fatalities (12/15, 80.0%) happened within
the first 7 days, as in other reports.25 High prevalence of
EOD and case fatality in this study further underscores
effectiveness of intrapartum antibiotic prophylaxis in
Taiwan as in other countries.5,26e28
Readers might suspect selective bias because it is mainly
from medical centers that might have more high-risk preg-
nant women and high social-economic class with a high
prevalence. To overcome this bias,we did a small sample size
by purposive sampling, as suggested by a statistical expert.
We hired medical assistants to explain thoroughly to every
pregnant woman and persuaded her to receive GBS culture
from April to June 2005 in two medical centers. Colonization
rate was around 18%, nearly the same as in the six hospitals.
5. Conclusions
With GBS colonization of pregnant women, incidence of
EOD and mortality rate nearly the same as those in other
countries, universal maternal rectovaginal culture of GBS
with subsequent intrapartum antibiotics prophylaxis is
mandatory for reducing EOD and mortality of neonatal GBS
infection in Taiwan.Acknowledgments
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